Solriamfetol Hydrochloride and Telaprevir

• Generic Name: solriamfetol
• Dosage Forms: n.a.
• Other Brand Names: Sunosi

Solriamfetol hydrochloride is a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA).

Solriamfetol hydrochloride is not indicated to treat the underlying airway obstruction in OSA. Ensure that the underlying airway obstruction is treated (e.g., with continuous positive airway pressure [CPAP]) for at least one month prior to initiating solriamfetol hydrochloride for excessive daytime sleepiness. Modalities to treat the underlying airway obstruction should be continued during treatment with solriamfetol hydrochloride. Solriamfetol hydrochloride is not a substitute for these modalities.

• Generic Name: telaprevir
• Dosage Forms: n.a.
• Other Brand Names: Incivek

Telaprevir is used in combination with injectable peginterferon alfa (Pegasys®, Pegintron®) and ribavirin (Copegus®, Rebetol®) to treat chronic hepatitis C infection. These medicines are used in patients with liver disease (including cirrhosis) who have not been treated before or who have received other medicines that did not work well. Telaprevir is an antiviral agent.

Telaprevir was available only with your doctor's prescription.

Telaprevir was withdrawn from the United States market on October 16, 2014.